Tandem Diabetes Care
OverviewSuggest Edit
Tandem Diabetes Care is a medical device company that engages in the design, development, and commercialization of products for people with insulin-dependent diabetes. The company is primarily focused on manufacturing, sales, and support of its flagship pump platform, t:slim X2 Insulin Delivery System (t:slim X2), and complementary product offerings. Its hardware and software solutions and support services help people with diabetes and their healthcare providers improve diabetes therapy management.
| Type | Public | |
| Founded | 2006 | |
| HQ | San Diego, CA, US | Map |
| Website | tandemdiabetes.com | |
| Employee Ratings | More |
Recent NewsAll News
- Thinking about trading options or stock in Tandem Diabetes Care, Revolve Group, Callon Petroleum, Vir Biotechnology, or T-Mobile?
- Should you invest in Tandem Diabetes Care, Appian Corp, Novavax, Royal Caribbean Cruises, or Boeing?
- lobal Artificial Pancreas Systems Market Report 2019 Top Key Players- Medtronic, Johnson and Johnson, Dexcom, Insulet, Tandem Diabetes Care and more...
- SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tandem Diabetes Care, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Key People/Management at Tandem Diabetes Care
Kim D. Blickenstaff
Michael Fechko
John F. Sheridan
David Berger
Elizabeth Gasser
Tom Fox
Tandem Diabetes Care Office Locations
Tandem Diabetes Care Financials and Metrics
Tandem Diabetes Care Revenue
| USD | |
|---|---|
Revenue (FY, 2020) | 498.8m |
Gross profit (FY, 2020) | 260.5m |
Gross profit margin (FY, 2020), % | 52.2% |
Net income (FY, 2020) | (34.4m) |
EBIT (FY, 2020) | (8.0m) |
Market capitalization (26-Feb-2021) | 6.0b |
Closing stock price (26-Feb-2021) | 96.0 |
Cash (31-Dec-2020) | 94.6m |
EV | 6.1b |
| USD | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 21.3m | 27.0m | 27.3m | 34.1m | 46.3m | 66.0m | 93.3m | 94.7m | 109.2m | 123.6m |
Cost of goods sold | 13.3m | 15.1m | 15.9m | 19.0m | 24.5m | 32.6m | 43.4m | 44.0m | 54.8m | 58.3m |
Gross profit | 8.0m | 11.9m | 11.4m | 15.1m | 21.8m | 33.4m | 49.9m | 50.7m | 54.4m | 65.3m |
Gross profit Margin, % | 38% | 44% | 42% | 44% | 47% | 51% | 54% | 54% | 50% | 53% |
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Cash | 40.3m | 27.4m | 12.1m | 62.6m | 50.5m | 32.3m | 40.4m | 38.2m | 46.1m | 222.5m | 129.5m |
Accounts Receivable | 7.7m | 9.0m | 10.6m | 13.0m | 13.9m | 21.7m | 33.0m | 48.4m | 45.3m | 45.0m | 52.1m |
Prepaid Expenses | 4.5m | 2.5m | 2.9m | 2.9m | 3.0m | 3.0m | 4.6m | 6.0m | 3.6m | 6.1m | 5.0m |
Inventories | 23.7m | 25.8m | 30.0m | 26.5m | 24.9m | 24.4m | 22.8m | 27.3m | 40.7m | 62.3m | 70.6m |
| USD | Q1, 2017 | Q2, 2017 | Q3, 2017 | Q1, 2018 | Q2, 2018 | Q3, 2018 | Q1, 2019 | Q2, 2019 | Q3, 2019 | Q2, 2020 | Q3, 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | (23.8m) | (45.6m) | (61.6m) | (32.7m) | (92.1m) | (126.3m) | (23.0m) | (24.5m) | (27.4m) | (42.0m) | (51.4m) |
Depreciation and Amortization | 1.4m | 3.0m | 4.7m | 1.5m | 2.9m | 4.4m | 1.4m | 2.9m | 4.4m | 4.0m | 7.0m |
Inventories | (2.6m) | (4.8m) | (9.0m) | 342.0k | 2.0m | 2.8m | (3.7m) | (8.5m) | (22.0m) | (13.2m) | (22.1m) |
Accounts Payable | (2.7m) | (447.0k) | 522.0k | (1.7m) | (1.7m) | 1.1m | 4.4m | 2.2m | 7.1m | (324.0k) | 3.3m |
| USD | FY, 2016 |
|---|---|
Debt/Equity | -13.3 x |
Debt/Assets | 0.7 x |
Financial Leverage | -19 x |
Tandem Diabetes Care Revenue Breakdown
Tandem Diabetes Care revenue breakdown by geographic segment: 16.6% from International Sales and 83.4% from Domestic Sales
Tandem Diabetes Care Cybersecurity Score
Tandem Diabetes Care Environment, Social & Governance (ESG) Ratings
Tandem Diabetes Care Online and Social Media Presence
9.26k Twitter followers
Tandem Diabetes Care has 9.26k Twitter Followers. The number of followers has increased 0.9% month over month and increased 1.8% quarter over quarter
Tandem Diabetes Care's Trends
Twitter Engagement Stats for @TandemDiabetes
8.2k
Tweets
773
Following
9.3k
Followers
82
Tweets last 30 days
3.8
Avg. likes per Tweet
61%
Tweets with engagement
Tandem Diabetes Care News and Updates
Thinking about trading options or stock in Tandem Diabetes Care, Revolve Group, Callon Petroleum, Vir Biotechnology, or T-Mobile?
Should you invest in Tandem Diabetes Care, Appian Corp, Novavax, Royal Caribbean Cruises, or Boeing?
lobal Artificial Pancreas Systems Market Report 2019 Top Key Players- Medtronic, Johnson and Johnson, Dexcom, Insulet, Tandem Diabetes Care and more...
SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating Tandem Diabetes Care, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors
Tandem Diabetes Care Frequently Asked Questions
When was Tandem Diabetes Care founded?
Tandem Diabetes Care was founded in 2006.
Who are Tandem Diabetes Care key executives?
Tandem Diabetes Care's key executives are Kim D. Blickenstaff, Michael Fechko and John F. Sheridan.
How many employees does Tandem Diabetes Care have?
Tandem Diabetes Care has 1,043 employees.
What is Tandem Diabetes Care revenue?
Latest Tandem Diabetes Care annual revenue is $498.8 m.
What is Tandem Diabetes Care revenue per employee?
Latest Tandem Diabetes Care revenue per employee is $478.3 k.
Who are Tandem Diabetes Care competitors?
Competitors of Tandem Diabetes Care include Apria Healthcare Group, Acelity and Neurometrix.
Where is Tandem Diabetes Care headquarters?
Tandem Diabetes Care headquarters is located at 11075 Roselle St, San Diego.
Where are Tandem Diabetes Care offices?
Tandem Diabetes Care has an office in San Diego.
How many offices does Tandem Diabetes Care have?
Tandem Diabetes Care has 1 office.
Learn about Craft real-time company insights
Receive alerts for 300+ data fields across thousands of companies